Denis Dufrane

Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT.

ProterixBio, Inc. supplies novel protein measurement technology. It manufactures and markets the ViBE platform, enabling highly sensitive, automated acoustic immunoassays to accelerate drug discovery, development and production of biological and pharmaceutical products. The company was founded by Edward F. Crawley and Mark Lundstrom in 2002 and is headquartered in Billerica, MA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Avis Budget EMEA Ltd. provides vehicle rental services. Its customers include individual travelers booking directly or indirectly through travel companies, tour operators, partnership arrangements, and brokers; corporate customers booking via negotiated arrangements with their employers and through vehicle replacement companies; and insurance and leasing companies, vehicle dealerships, and repair shops. The company was founded by Warren E. Avis in 1946 and is headquartered in London, the United Kingdom.

GIB-INNO-BM SA operates as a holding company. The company is headquartered in Sint-Pieters-Woluwe, Belgium.

Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium.

D'IM SA engages in the provision of automotive glass repair and replacement services. The company is headquartered in Luxembourg.

Alcopa NV engages in the distribution of cars, motorbikes, scooters, and office furniture. Its business activities include Alcomotive, Alcopa Immo, Modis, Alcopa Auction, and Solar Screen. The company was founded by Albert Moorkens and Constance Moorkens in 1937 and is headquartered in Kontich, Belgium.

New Science Ventures LLC (New Science Ventures) is a venture capital firm founded in 2004 by Somasundaram Subramaniam and Tom J A Lavin. The firm is headquartered in Greenwich, Connecticut with additional office in London.

Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain.

Vlaams Instituut voor Biotechnologie - Flanders Institute operates as a non-profit organization, provides research and development services. It specializes in translating basic scientific results into pharmaceutical, agricultural and industrial applications. The company was founded on January 1, 1996 and is headquartered in Ghent, Belgium.

Axxis V & C BV is a Belgian company that provides business and management consulting services. The company is based in Haasrode, Belgium. The company was founded in 1998 and the CEOs are Gil Beyen, Nadine Buyle, and Willem Beyen.

Altamar Private Equity SGIIC SA (Altamar Private Equity) is a private equity arm of Altamar Capital Partners SL founded in 2004. The firm is headquartered in Spain with additional offices in New York and Santiago de Chile.

Henogen SA develops and manufactures biopharmaceuticals. The company was founded on November 19, 1999 and is headquartered in Charleroi, Belgium.

Xylowatt SA designs, develops and builds gasification reactors for energy conversion from biomass and waste products. It offers NOTAR gasification reactor that produces syngas; and expert services. The company’s products convert energy from clean wood waste, contaminated wood, creosoted wood, radionuclides contaminated wood, agro residues, and sewage sludge. Its product is used in CHP and industrial applications. The company was founded in 2001 and it is headquartered in Charleroi, Belgium.

GreenWatt SA designs and installs on-site bio-methanization plants. It engages in the provision of renewable energy and recycling solutions for waste bio-methanization cogeneration. The company was founded by Marc-Jean Spiltoir, Patrick Alexandre Thierry Rene van den Broucke, and Therese Marie Wathelet Florence in 2004 and is headquartered in Louvain-la-Neuve, Belgium.

DNAVision SA operates as a research and development company. The firm provides genomic services to the pharmaceutical, food and biotechnology industries. It offers Non-Executive Directortgen seqencing, bioinformatics, sanger sequence, expression profiling, DNA extraction and biobanking. The company was founded in May 2004 and is headquartered in Charleroi, Belgium.

FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen.

Federation of Enterprises in Belgium ASBL/VZW fka Federation des Entreprises de Belgique is the only multi-sector employers' organization representing companies in all three regions of Belgium. Its members, Belgium's leading sectoral federations, represent companies in key industrial and service sectors. The company was founded in 1973 and is headquartered in Brussels, Belgium.

Mckinsey & Co. SAS provides business and management consulting services. The company is headquartered in Paris, France.

Arthur D. Little Benelux NV SA is a global management consultancy specializing in strategy and operations management, serving major corporations and organizations worldwide. They are recognized as leaders in linking strategy, innovation and technology to solve their clients' most complex business issues, delivering sustainable solutions. They are distinguished from others by their deep industry insight and technology expertise. The company was founded in 1967 and is headquartered in Brussels, Belgium.

ImCyse SA engages in the development of curative therapies in the field of immune and allergic pathologies. It offers a technological platform that helps develop medicinal products with potential benefits in all clinical circumstances where HLA class II restricted specific immunity can be causative of or contribute to damages to humans or animals. The firm's products are used in organ-specific autoimmunity, allergy, alloimmunity, cancer and infectious diseases. The company was founded in August 2010 by Jean-Marie R. Saint-Remy and is headquartered in Liege, Belgium.

iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium.

Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain.

Fund+ is an independent Venture Capital firm founded in 2015. The firm is headquartered in Leuven, Belgium.

Aelix Therapeutics SL researches and develops therapies for HIV. It develops therapeutic vaccines and immunotherapies to treat HIV infection. The firm is a spin-off of HIVACAT, the Catalan project for the development of effective vaccines against HIV. The company was founded by Christian Brander, Bonaventura Clotet, Josep Maria Gatell and Jordi Naval is headquartered in Barcelona, Spain.

eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium.

Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France.

Morrow NV develops researching technology for digital lenses. It provides eyecare services. The company was founded by Jelle de Smet and Paul Marchal and is headquartered in Zwijnaarde, Netherlands.

ImmunOs Therapeutics AG is a company based in Schlieren, Switzerland that pioneers HLA-based therapeutics to create transformational medicines for cancer and inflammation. The Swiss company has identified specific HLA molecules that activate the immune system and is utilizing these molecules as the backbone of novel therapies capable of stimulating both the innate and adaptive immune systems of cancer patients to eliminate tumor cells. ImmunOs' lead program is a multi-functional fusion protein that blocks specific LILRB and KIR receptors and activates anti-tumor responses. The company is also using HLA molecules to develop novel therapies to treat inflammatory diseases. ImmunOs is supported by leading international investors, including Samsara BioCapital, Lightspeed Venture Partners, Gimv, Pfizer Ventures, Biomed Partners, Schroder Adveq, Mission BioCapital, GL Capital, Peak6, Fiscus, and Redalpine. The company was founded by Osiris Marroquin Belaunzaran and Christoph Renner, and the CEO is Sean R. Smith.

Exevir Bio BV is engaged in biotechnology services. The company is headquartered in Zwijnaarde, Belgium.

Exothera SA is a Belgian company that manufactures and develops viral vector and nucleic acid. The private company is based in Jumet, Belgium. The company was founded in 2020 by José Fernandez Castillo, Hugues Bultot. The CEO is Thibault Jonckheere.

Power 2 Green NV is a Belgian company that was founded in 2016. The private company is based in Liege, Belgium. The company trades, rents, and operates real estate and non-residential properties.

THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations.